Artificial intelligence technology has tripled the number of U.K. stroke patients healing to a point where they can perform daily activities, according to new research released Tuesday.
Early-stage analysis of over 111,000 suspected stroke patients whose care retained the use of the technology found it reduced the period between being seen by a doctor and medicine beginning by more than 60 minutes, leading to improved results.
The balance who were able to resume day-to-day activities increased from 16 to 48 percent, the analysis of the Brainomix e-Stroke imaging platform found.
The technology, created by the UK’s med-tech solution firm Brainomix, is being used across 11 stroke treatment networks in the UK’s state-funded National Health Service (NHS) to analyze strokes and determine the best treatment.
The forum helps doctors in the interpretation of brain scans and allows them to share the images with specialists worldwide who can access them remotely.
AI can transform our NHS — delivering faster, more accurate diagnoses and making sure patients can get the treatment they need when they need it, the U.K.’s health secretary Steve Barclay said in a report.
Brainomix is an excellent example of how this can be achieved, using the power of AI to shave lifesaving minutes off one of the most time-sensitive diagnoses in treatment.
Patient Carol Wilson, a teaching assistant, said the prompt diagnosis and treatment she obtained as a result of the technology meant she was posing up and texting her family later the same day.
Artificial spying technology has tripled the number of UK stroke patients recovering to a point where they can complete daily activities, according to new research released on Tuesday.
Early-stage research of over 111,000 suspected stroke patients whose care included the use of the technology found it reduced the time between being seen by a doctor and medicine beginning by over 60 minutes, leading to improved results.
The proportion who were able to continue day-to-day activities increased from 16 to 48%, the analysis of the Brainomix e-Stroke imaging platform found.
The technology, developed by the UK’s med-tech resolution firm Brainomix, is being used across 11 stroke treatment networks in the UK’s state-funded National Health Service (NHS) to diagnose strokes and choose the best treatment.
The platform helps physicians in the interpretation of brain scans and allows them to share the images with specialists worldwide who can access them remotely.
“AI can transform our NHS – delivering faster, more accurate diagnoses and making sure patients can get the medicine they need, when they need it,” the UK’s health secretary Steve Barclay said in a statement.
“Brainomix is an outstanding example of how this can be achieved, using the power of AI to shave lifesaving minutes off one of the most time-sensitive diagnoses in treatment.”
Patient Carol Wilson, a teaching associate, said the rapid diagnosis and therapy she received as a result of the technology meant she was sitting up and texting her family later the same day.
The grandmother who has back returned to work said she was “back home and able to walk around two days after having a stroke”.
Over 85,000 people mourn a stroke in the UK each year.
NHS England’s head of Transformation Dr. Timothy Ferris said the medicine was harnessing the possibility that AI has to support expert staff in delivering life-changing care”.
“Every minute held during the initial hospital assessment of people with stroke-like symptoms can dramatically enhance a patient’s chance of leaving the hospital in good health,” he said.
Brainomix launched as an Oxford University spin-out in 2010. Its e-stroke platform is now used in over 330 hospitals in over 30 countries.
Early-stage analysis of over 111,000 suspected stroke patients whose care included the use of the technology found it reduced the time between being seen by a doctor and medicine beginning by over 60 minutes, leading to improved results.
The proportion who were able to continue day-to-day activities increased from 16 to 48 percent, the analysis of the Brainomix e-Stroke imaging platform found.
The technology, created by the UK’s med-tech resolution firm Brainomix, is being used across 11 stroke medicine networks in the UK’s state-funded National Health Service (NHS) to analyze strokes and determine the best treatment.
The forum helps doctors in the interpretation of brain scans and allows them to share the images with specialists worldwide who can access them remotely.
AI can transform our NHS — delivering faster, more accurate diagnoses and making sure patients can get the medicine they need when they need it, the UK’s health secretary Steve Barclay said in a statement.
